Are Research Peptides Legal in Malaysia?

How Malaysia classifies research peptides

The Control of Drugs and Cosmetics Regulations 1984, administered by the National Pharmaceutical Regulatory Agency (NPRA) under the Ministry of Health, governs products that are marketed or intended for human therapeutic use. A product falls under that framework — and needs NPRA registration — once it is represented as a medicine, treatment or supplement.

Classification is compound-by-compound, and it is not the same answer for everything in this catalogue. Some research peptides are not scheduled under the Poisons Act 1952 or the Dangerous Drugs Act 1952. Others are: GLP-1 receptor agonists, tirzepatide among them, are Group B Poisons under the Poisons Act 1952, which restricts their supply for medical treatment to registered medical practitioners and pharmacists dispensing against a prescription. Separately, a compound can be unscheduled and still be unregistered with the NPRA — retatrutide, for example, is investigational and has no Malaysian product registration. Anyone sourcing a specific compound should establish its status for themselves rather than assume a single rule covers the category.

What "for research use only" means in practice

Research use only describes what we sell and how we sell it: no therapeutic claims, no human or veterinary dosing instructions, no representation of any compound as a treatment. It is a statement of scope, not an exemption — a research-use label does not change how a scheduled substance is classified, and it does not put any compound outside the reach of Malaysian law.

Everything Clarus Molecular lists is sold on that basis: research use only, no therapeutic claims, no dosing instructions for human or animal administration. See our disclaimer for the full framing.

Why documentation matters regardless of legal status

Classification is one question; whether the material is what it claims to be is a separate one. A Certificate of Analysis — independent mass-spectrometry identity confirmation plus HPLC purity data — is the only way to verify that. Our COA guide covers what to look for.

This is not legal advice

This page is general background, not legal advice, and not a statement of the status of any particular compound. Regulatory classification changes, and it differs compound by compound. Anyone with a specific question about their own situation — including whether a given compound is scheduled — should consult a Malaysian legal practitioner familiar with pharmaceutical and chemical regulation, and check the current Poisons List and NPRA registers directly.